Global Information
회사소개 | 문의

세계의 체외진단(IVD) 검사 시장 : 제11판

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition

리서치사 Kalorama Information
발행일 2018년 08월 상품 코드 235126
페이지 정보 영문 1888 Pages
가격
US $ 7,500 ₩ 8,545,500 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF파일의 Copy & Paste 기능은 물리적으로는 가능하나, 리서치사에서는 이를 허용하고 있지 않습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,250 ₩ 12,818,200 PDF by E-mail (Site License - 1 Location, 10 Users)
US $ 15,000 ₩ 17,091,000 PDF by E-mail (Corporate License)


세계의 체외진단(IVD) 검사 시장 : 제11판 The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition
발행일 : 2018년 08월 페이지 정보 : 영문 1888 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 체외진단(IVD : In Vitro Diagnostic) 검사 시장에 대해 조사했으며, 인구 및 질환 통계 등의 시장 배경, 시장 전체의 주요 동향과 혁신, 검사 구분별 시장 분석, 기술 동향, 시장 규모 추정과 예측·향후 전망, 주요 사업자 개요 등의 정보를 전해드립니다.

제1장 주요 요약

제2장 서론

제3장 체외진단 : 세계적 전망

  • 배경
  • 세계의 고령화
  • 질환에 의한 부담 변화
  • 신흥 시장과 선진 시장
  • 세계의 IVD 시장 : 시장 규모와 예측
  • 미국의 IVD 시장 : 일부 회복
  • 동유럽에서의 시장 기회
  • 일본
  • 중국
  • 인도
  • 아시아 기타 지역
  • 브라질
  • 멕시코
  • 러시아
  • 캐나다
  • 신흥 시장

제4장 기업 및 산업 동향

  • 서론
  • 유전자 편집
  • 마이크로바이옴
  • 액체생검
  • IT의 주목
  • 엑소좀 시퀀싱
  • 비오틴 간섭 및 면역측정 에러
  • 미량 혈액 검사
  • 차세대 시퀀싱 : 당국의 추진 의사를 나타내는 3개 신호
  • 고감도 심근 트로포닌 측정
  • 블록체인
  • 약물 남용 등

제5장 POC 검사

  • 개요와 동향
  • 주요 기업
  • POC 감염증 검사
  • 결핵
  • 호흡기 질환
  • 당뇨병 검사 : 혈당 모니터링
  • 약물 남용 검사

제6장 코어랩(Core Lab)

  • 개요와 동향
  • 커넥티비티
  • 화학 검사 개요
  • 시장 분석
  • 수면무호흡증 검사
  • 화학 검사 : 상업적 전망

제7장 면역측정

  • 개요와 동향
  • 시장 분석
  • 성숙 상태 어세이 부문
  • 성숙화로 향하는 면역측정
  • 성장 과정 면역측정
  • 면역측정 : 상업적 전망

제8장 분자 어세이

  • 개요
  • 샘플 조제와 품질 관리
  • 첨단 분자 검사와 기술
  • 주요 기업
  • 시장 분석
  • 조직 적합 검사
  • 분자 검사 : 상업적 전망

제9장 혈액 검사

  • 개요와 동향
  • 실험실 기반 혈액검사
  • 분산형 혈액 검사
  • 시장 분석과 주요 공급업체
  • 혈액 검사 : 상업적 전망

제10장 응고 검사

  • 개요와 동향
  • 특수 항목
  • 시장 분석
  • 실험실 기반 검사
  • 주요 공급업체 : 실험실 시스템
  • 분산형 응고 검사 : 전문 이용
  • 주요 공급업체 : POC 시스템
  • 응고 검사 : 상업적 전망

제11장 미생물 검사 및 바이러스 검사

  • 감염증의 부담
  • 비검출 간접 비용 : 이차적 효과
  • 미생물의 항생물질 내성 : 임상시험의 중요성
  • 기존의 미생물 검사와 그 제약
  • 새로운 미생물 검사 : 혁신
  • 새로운 감염증의 위협
  • 미생물 관련 기업의 조합
  • 시장 분석
  • 시장 분석 : 기존 미생물 ID/AST
  • 시장 분석 : 미생물 면역측정
  • 시장 분석 : 분자 미생물 검사
  • 클로스트리듐 디피실
  • 질량 분석
  • 미생물 검사 : 향후 전망

제12장 혈액은행 서비스

  • 서론
  • 세계의 채혈 상황
  • 혈액의 안전성
  • 혈액 및 혈액성분 수집
  • 수혈의 재평가
  • 혈액형 판정 시장
  • 혈액 검사 시장
  • 혈액은행용 검사 : 상업적 전망

제13장 조직 검사 및 세포 검사

  • 개요
  • 전문 토픽
  • 시장 분석
  • 조직 검사와 세포 검사 : 상업적 전망

제14장 기업 개요 : Top Tier 사업자

제15장 기업 개요 : Second Tier 사업자

제16장 기업 개요 : 혈액은행 전문 사업자

제17장 기업 개요 : 응고 검사 전문 사업자

제18장 기업 개요 : 코어랩 및 기타 관련 사업자

제19장 기업 개요 : CTC 및 액체생검법 검사 프로바이더

제20장 기업 개요 : 당뇨병 전문 사업자

제21장 기업 개요 : 혈액 검사(세포 분석) 전문 사업자

제22장 기업 개요 : 병리조직 검사 전문 사업자

제23장 기업 개요 : 면역측정 전문 사업자

제24장 기업 개요 : 체외진단용 IT 전문 사업자

제25장 기업 개요 : 미생물 검사 전문 사업자

제26장 기업 개요 : 분자 검사 전문 사업자

제27장 기업 개요 : POC 검사 전문 사업자

제28장 기업 개요 : 출생전 진단 서비스 프로바이더

제29장 기업 개요 : 품질 관리 및 시료 사전처리 전문 사업자

제30장 기업 개요 : 검사 서비스 프로바이더

KSM 18.09.03

While 70 percent of critical healthcare decisions are made with the aid of a clinical test, testing amounts for a small portion of total healthcare spending. Plus testing has the ability to better target therapy and lower costs. That's why there is continued interest from healthcare providers worldwide in in vitro testing products, and why the IVD industry maintains a high level of investor interest.

In 2018, the market continues to evolve. Microbiome, Big Data, Next Generation Sequencing, AI, Robotics are among the trends shaping this market. Only a market research firm grounded with experience covering diagnostics over a long history can identify how trends will impact the market. That's why Kalorama Information's in vitro diagnostic reporting has been utilized by top companies and industry investors.

Now in its 11th edition, The Worldwide Market for In Vitro Diagnostic (IVD) Tests is the most essential report on the IVD industry. The report has been updated for two decades in eleven editions, keeping readers informed about developments in all areas of the IVD industry, around the world, in one volume. The 1,800-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market.

Current 2018 IVD Market Estimates For Essential Segments

The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2023 for defined segments of the IVD market and various sub-segments, including:

  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
  • Clinical Chemistry and "Core Lab" Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
  • Point-of-Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
  • Substance Abuse Testing
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
  • Tissue-Based Testing - Histology and Cytology (Pap, ISH, IHC, HPV)
  • Infectious Disease Immunoassay Testing (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
  • Hematology
  • Flow Cytometry
  • Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others)
  • Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
  • Coagulation Tests (Lab-Based, POC, Genetic Markers)
  • Mass Spectrometry
  • Molecular Point-Of-Care
  • Next Generation Sequencing
  • Direct-to-Consumer Testing

The report also tracks hundreds of competitors, notes significant partnerships, distribution deals and acquisitions and defines the market share situation for the in vitro diagnostic market and competitive analysis for many segments.

The Future of IVD: Market Segment Projections to 2023

For each of the listed in vitro diagnostics market segments, 2018 in vitro diagnostics market size, 2023 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends. The Worldwide Market for In Vitro Diagnostic Tests has been called "The Bible of the IVD Industry" by customers, which include top IVD firms. Using Kalorama Information's The Worldwide Market for In vitro Diagnostic (IVD) Tests, 11th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

The Global Market Regional and Country IVD Markets

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:

  • US
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Netherlands
  • Turkey
  • Poland
  • Canada
  • China
  • Japan
  • Saudi Arabia
  • Brazil
  • Eastern Europe
  • Emerging Markets
  • Rest of World

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2018.

Superior In Vitro Diagnostic Company Profiles

Kalorama Information's report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition contains hundreds of profiles of companies operating within the in vitro diagnostics industry. Top-tier IVD companies such as Roche Diagnostics, Abbott, Siemens, Beckman Coulter, bioMerieux, Qiagen and Ortho Clinical Diagnostics are discussed at great length and hundreds of smaller companies are detailed. Modest in vitro diagnostics technology growth in developed countries, stronger growth in developing countries with a simultaneous shift from a preoccupation with infectious diseases to chronic conditions, is expected. Also discussed within the report is increased privatization of healthcare services throughout the world, developed and emerging economies included and thus increased pricing pressure on all devices including in vitro diagnostics technology.

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.

The report covers both the dominant companies in the in vitro diagnostics industry and the fast up-and-comers for a complete picture of the market. For each company, extensive, discussion of recent financial performance is provided. These IVD manufacturers' main products are detailed and any significant company strategies, partnerships and acquisitions are considered:

  • Abbott Diagnostics
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories
  • Hologic
  • Instrumentation Laboratory (IL)
  • Ortho Clinical Diagnostics (OCD)
  • QIAGEN N.V
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo FisherScientific
  • Werfen Group S.A.
  • ERBA Diagnostics, Inc
  • DiaSorin S.p.A
  • Illumina
  • Luminex Corporation
  • Menarini Diagnostics.
  • Mindray Medical International Limited
  • Myriad Genetics
  • Perkin Elmer, Inc. (PE)
  • Quidel Corporation
  • Randox Laboratories Ltd
  • Royal Philips
  • TOSOH Corporation
  • Trinity Biotech
  • Wako Pure Chemical Industries

Specialist In Vitro Diagnostic Companies:

While these IVD manufacturers and companies focus on one segment of the in vitro diagnostic market, they can often be dominant in the market as well. They are important to watch because they can often develop products in new areas of testing and move categories.

  • Molecular Specialists
  • Test Services Specialists
  • Diabetes Specialists
  • Blood Banking Specialists
  • Point of Care Specialists
  • Prenatal Test Service Providers
  • Quality Control and Pretreatment Specialists
  • Coagulation Specialists
  • Histology and Cytology Specialists
  • Microbiology Specialists
  • IT Solutions Companies
  • CTC and Liquid Biopsy Specialists

Deep Understanding of In Vitro Diagnostic Market Trends

Published continuously for two decades, the report reflects the experience Kalorama has in watching events in IVD and the emergence and reemergence of industry, technological and clinical trends. For instance:

The revolution in bioinformatics is allowing clinical and traditional medical engineering to blend with components derived from the telecommunications, information and computer sciences industries. This opens new niche markets for POC test devices, which will have a positive impact on diagnostic testing.

Getting information to care givers and patients is now not an added plus, it is a prerequisite of all lab operations. Thus the next 3-5 years will see an intensification of the healthcare industry's emphasis on informatics, wireless communications, data networking and cost/effective healthcare delivery.

In the area of test economics, outcomes based disease management establishes guidelines and directives for patient care. This is having a significant effect on the use of new tests, which have to prove their added value to patient care. It also affects how many and which tests are recommended and thus reimbursed for a specific disease group.

None of the above would be happening without significant forces in the in vitro diagnostics market driving them. Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition presents the trends, technologies, customer needs and major suppliers in the in vitro diagnostics market with an eye on how they are shaping the IVD industry, including the following industry trends:

  • Gene Editing and IVD
  • Next Generation Sequencing
  • Disease Trends
  • Retail Clinics
  • Direct-to-Consumer Testing
  • Lab-Developed Tests
  • Top 20 In Vitro Diagnostic Companies and Niche Players
  • Status of IVD M&As in 2018
  • Emerging Markets, Emerged Markets and "Next Wave" Emerging
  • Digital Technology, IT and Big Data
  • Europe Slight Recovery
  • State of Biomarker Discovery
  • Test Services Trend
  • Distribution Agreements
  • Role of Sequencing
  • Non-Blood Sampling
  • LDT Regulatory Picture
  • New Product Launches
  • Near-Patient Testing

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: The Worldwide IVD Market, 2018 -2023 ($millions)
  • SCOPE AND METHODOLOGY
    • Table 1-1: Exchange Rate Fluctuations, 2012-2016
  • SIZE AND GROWTH OF THE MARKET
    • Figure 1-2: Regional Distribution of IVD market, 2018
    • Table 1-2: Worldwide In Vitro Diagnostic Reagent Sales by Market Segment, 2016-2021 ($ million)
  • COMPETITIVE PICTURE IN IVD
  • IVD MARKET HIGHLIGHTS
  • WHAT TO WATCH
  • LAB MEDICINE DISCIPLINES AND APPLICATIONS

TWO: INTRODUCTION

  • A PARADOX OF SORTS
  • REPORT DESIGN
  • THE CHALLENGE OF PAMA
  • MARKET ANALYSIS OF IVD MARKET SEGMENTS
    • Table 2-1: Worldwide In Vitro Diagnostic Sales by Product Market, 2018-2023 ($ million)
  • TOP SUPPLIERS AND NICHE PLAYERS
  • Introduction
  • Overview of the Top Tier Companies
    • Table 2-2: Revenues of Selected Top IVD Companies, 2013-2017 ($ million, estimated)
  • Overview of Selected Second Tier Companies
    • Table 2-3: Revenues of Selected Niche Players, 2013-2017 ($ million)
  • IVD COMPANIES MIX AND MATCH
    • Table 2-4: Selected Diagnostics Industry Acquisitions, 2016, 2017, & 2018
  • MARKET EXPANSION INITIATIVES
    • Table 2-5: Selected Market Geographic or Product Expansion Initiatives
  • DISTRIBUTION AGREEMENTS
    • Table 2-6: Selected Diagnostics Industry Distribution Agreements, H2 2016, 2017, 2018
  • LICENSES AND COLLABORATION AGREEMENTS
    • Table 2-7: Selected IVD Partnerships/Collaborations/Licensing Agreements, H2 2016, 2017, 2018
  • TEST SERVICES
    • Table 2-8: Selected Test Services, Sales 2012-2016 ($ millions, estimated where applicable)
    • Table 2-9: Lab Market Segmentation, Worldwide, 2018 (estimated)
    • Table 2-10: Revenues for a Selection of U.S.-based Reference Labs, 2012-2016 ($ million, estimated)
    • Table 2-11: Selected Company-Sponsored Labs Established 2015-2017
  • IVDS THEN AND NOW - A 22 YEAR PERSPECTIVE
  • In the Beginning to Now
    • Figure 2-1: Share of IVD Market by Segment, Percentage, 2000 and 2018 Compared
  • Future
  • POINT OF VIEW

THREE: THE GLOBAL PICTURE FOR IN VITRO DIAGNOSTIC MARKETS

  • BACKGROUND
  • Simultaneous Threats: Chronic and Acute
  • Expected World IVD Market Developments
  • THE AGING PLANET
    • Table 3-1: Elderly Support Ratio in Various Countries
  • Workforce Reduction
    • Table 3-2: Age Under 15 and Over 65, by Continent
  • Is the World Prepared for Aging?
  • SHIFTING DISEASE BURDENS
    • Table 3-3: Changing DALY ranking of Disease Threats (disability-adjusted life year) Worldwide
  • Increase in Chronic Diseases
  • EMERGING AND EMERGED MARKETS
    • Table 3-4: Available Market Data, 2017
  • Emerging Nations and Health Insurance
  • SIZE AND FORECAST FOR THE WORLD IVD MARKET
    • Table 3-5: Worldwide In Vitro Diagnostic Market by Country, 2018 and 2023
  • THE IVD MARKET IN THE UNITED STATES
  • PAMA and Reimbursement Changes
  • LDT Oversight Update
  • Rare Disease Testing
  • Personalized Medicine
    • Table 3-6: United States IVD Market by Segment
  • IVD MARKET IN EUROPE: SOME RECOVERY
    • Figure 3-1: Europe: Growth in Healthcare Expenditure by Country, 2012-2017 vs. 2017-2022
  • Industry Punches Back
    • Table 3-7: European IVD Market by Country, 2018 ($million)
  • European Directive 98/79/EC
  • Individual Country Markets
    • Table 3-8: IVD Market Per Capita, Europe
  • Personalized Medicine in Europe
  • Brexit
  • Austerity
  • OPPORTUNITY IN EASTERN EUROPE
    • Figure 3-2: Growth in Healthcare Expenditure in Eastern Europe, 2012-2017 vs. 2017-2022
    • Table 3-9: Eastern Europe In Vitro Diagnostic Sales by Country, 2018-2023 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Slovenia, Ukraine, Other Eastern Europe, Total)
  • JAPAN: SECOND-LARGEST COUNTRY MARKET
  • CHINA: LARGEST FAST-GROWER
    • Table3-10: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
  • Clinical Laboratory Tests in China
    • Figure 3-3: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015
  • Private Laboratories
  • Distribution in China
  • INDIA: HOME TO EVERY SIXTH PERSON IN THE WORLD
  • Labs in India
  • REST OF ASIA
    • Figure 3-4: Growth in Health Expenditure in Asia, 2012-2017 vs. 2017-2022
  • BRAZIL: LATAM LEADER
  • Disease Trends
  • IVD Market
  • MEXICO
  • THE RUSSIAN FEDERATION
  • CANADA
  • EMERGING MARKETS
  • Saudi Arabia
  • South Africa
  • Turkey IVD Market
    • Figure 3-5: Selected Emerging Growth in Health Expenditure, 20012-2017 vs. 2017-2022
  • Columbia IVD Market
  • United Arab Emirates (UAE)
  • South Korea
  • Other Markets to Watch

FOUR: COMPANY AND INDUSTRY TRENDS

  • INTRODUCTION
  • GENE EDITING
    • Table 4-1: Selected Gene Editing / CRISPR Innovations
  • MICROBIOME
    • Table 4-2: Selected Microbiome Test Innovations
  • LIQUID BIOPSY
    • Table 4-3: Liquid Biopsy: Selected Liquid Biopsy Innovations
  • INFORMATION TECHNOLOGY TAKES CENTER STAGE
    • Table 4-4: Selected IT Innovations
  • EXOSOME SEQUENCING
    • Table 4-5: Selected Exosome Test Innovations
  • BIOTIN INTERFERENCE IN IMMUNOASSAY DETECTION ERRORS
    • Table 4-6: Biotin-free Offerings Currently on the Market
  • SINGLE DROP BLOOD TESTS
  • Theranos
  • Genalyte
  • NOWDiagnostics
  • ApolloDx
  • 1Drop Diagnostics
  • Abbott i-STAT System
  • Siemens Healthineers epoc Blood Analysis System
  • Seventh Sense Biosystems
  • THREE SIGNS REGULATORS ARE CLEARING A PATH FOR NEXT GENERATION SEQUENCING
  • 1. The FDA Released Regulatory Guidance
  • 2. More NGS Tests Are Getting FDA Approval
  • 3. Medicaid Is Willing to Pay for NGS Tests
  • HIGH-SENSITIVITY CARDIAC TROPONIN TESTS FINALLY REACH THE U.S.
  • Detecting Heart Attacks Faster
  • Beyond Heart Attacks
  • LAB TEST HARMONIZATION GETS A $2 MILLION BOOST
  • BLOCKCHAIN
  • SUBSTANCE ABUSE
  • Opiod Epidemic
  • Biomarkers and Substance Abuse
  • Clinical Laboratory Testing for Drugs of Abuse
    • Table 4-7: Global Drug Abuse Statistics
  • Urine
  • Blood
  • Oral
  • Hair
    • Table 4-8: Selected Opioid FDA Approvals, 2015-2018

FIVE: POINT-OF-CARE TESTS

  • OVERVIEW AND TRENDS
  • Professional POC
    • Table 5-1 Professional POC Test Sales by Category, Worldwide 2018 -2023 ($million)
    • Table 5-2: Hospital POC Test Usage, U.S. (% of hospital using; % of hospitals not using)
    • Table 5-3: POC Test Use among Survey Respondents, Current and Desired
    • Table 5-4: Selected Profession POC Test Innovations
  • OTC Self Testing
    • Table 5-5: POC Self-Test Sales by Category, Worldwide, 2018-2023 ($million)
  • Colon Cancer Screening
  • Lipid Testing
  • THE MAJOR POC TEST PLAYERS
    • Table 5-6: POC Test Revenues of Selected IVD Companies, 2013-2015 ($ million, estimated)
  • POC INFECTIOUS DISEASE TESTING
    • Table 5-7: Selected Molecular POC Platforms Currently on Market
  • Products
  • HIV and Hepatitis Testing and Monitoring
  • Tuberculosis
  • Tropical and Neglected Diseases
  • Respiratory Diseases
  • Sepsis and Nosocomial Disease
  • Sexual Health
    • Table 5-8: Innovations in Molecular POC Infectious Disease Diagnostics
  • Market Size and Growth
  • DIABETES TESTING - BLOOD GLUCOSE MONITORING
  • Glucose Testing in Tight Economics
  • IT to Aid Diabetes Management
    • Table 5-9: Selected Apps and Glucose Management IT
  • Diabetes Market Analysis
    • Table 5-10: Diabetes Sales by Test Category, Worldwide, 2018-2023 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
  • Blood Glucose Self-Testing
    • Table 5-11: Selected Glucose Self-Test Meter Innovations
  • Noninvasive Testing Devices
    • Table 5-12: Selected Noninvasive Glucose Monitoring Devices
  • Continuous Self Testing en Route to the Artificial Pancreas
    • Table 5-13: Selected Continuous Blood Glucose System Developments
  • Blood Glucose Testing by Professionals
    • Table 5-14: Selected Innovations in Hospital-based Glucose Monitoring
  • Diabetes Testing - Glycated Hemoglobin
    • Table 5-15: Selected POC HbA1c Devices
  • Genes and Other Markers of Diabetes
    • Table 5-16: Selected POC Diabetes Monitoring Tests
  • DRUG OF ABUSE TESTING
  • Products
    • Table 5-17: Drugs of Abuse Tests on the Market

SIX: THE CORE LAB

  • CORE LAB OVERVIEW AND TRENDS
    • Table 6-1: Workstation Sales, 2018-2023 (General Chemistries, Immunos on workstations; $ millions)
    • Table 6-2: Core Lab Sales of the Top Five Manufacturers, 2014-2017 ($ millions, estimated)
    • Table 6-3: Selected New Analytes for the Core Lab, 2016-2018
  • CONNECTIVITY
  • OVERVIEW OF CHEMISTRY TESTS
  • Lab Automation
    • Table 6-4: Selected Lab Automation Innovations
  • Service Plans
  • MARKET ANALYSIS
    • Table 6-5: Worldwide Clinical Chemistry Sales by Test Category, 2018-2023 ($millions)
    • Table 6-6: Major Clinical Chemistry Companies
    • Table 6-7: Selected Clinical Chemistry Innovations
  • Rapid Response Systems
    • Table 6-8: Major Whole Blood Chemistry Analyzers
  • Critical Care Analysis
  • User Apps
    • Table 6-9: Selected Apps, Critical Care and Urinalysis IT Innovations, 2016
  • Urinalysis
    • Table 6-10: Selected Urinalysis Innovations, 2016
  • SLEEP APNEA TESTING: CORE LAB SOLUTION?
  • THE COMMERCIAL OUTLOOK FOR CHEMISTRY TESTS

SEVEN: IMMUNOASSAYS

  • OVERVIEW AND TRENDS
  • Immunoassay Technology Continues to Evolve
    • Table 7-1: Selected Immunoassay Technologies 2017
  • Mass Spectrometry
    • Table 7-2: Selected Innovation in Mass Spectrometry for Routine Analyses
  • Immunoassays in the Core Lab
    • Table 7-3: Selected Immunoassay Innovations on Core Lab Instruments
  • Radioimmunoassays
  • MARKET ANALYSIS
  • Leading Suppliers and Growth Potential
    • Table 7-4 Worldwide Lab-based Immunoassay Sales by Analyte Type, 2018-2023
    • Table 7-5: Selected Immunoassay Quality Control Products
    • Table 7-6: 2017 Revenue of Leading Immunoassay Vendors (in millions $)
  • MATURE ASSAY SEGMENT
  • Thyroid Function
  • Therapeutic Drug Monitoring
  • Anemia
  • Toxicology/DAU
  • Allergy
  • MATURING IMMUNOASSAYS
  • Proteins
  • GROWTH IMMUNOASSAYS
  • Vitamin D
    • Table 7-7: Selected Vitamin D Immunoassays 2015-2017
  • Tumor Markers
    • Table 7-8: Selected Tumor Marker Innovations 2015-2017
  • Cardiac Markers
    • Table 7-9: Selected Cardiac Marker Innovations
  • Autoimmune
    • Table 7-10: Selected Autoimmune Test Innovations
  • Rheumatoid Arthritis
    • Table 7-11: Selected Arthritis Immunoassay Innovations
  • Gastrointestinal Disorders
    • Table 7-12: Selected Inflammatory Bowel Disease Test Innovations
  • Transplant Management
    • Table 7-13: Selected Immunoassays for Transplant Medicine
  • Women's Health
    • Table 7-14: Selected Women's Health Innovations
  • Alzheimer's Disease
    • Table 7-15: Selected Innovations for Alzheimer's Disease Immunoassays
  • Sleep Apnea
  • Miscellaneous
    • Table 7-16: Selected Immunoassay Innovations
  • Point-of-Care OTC and Professional Use
    • Table 7-17: POC Immunoassay Test Sales by Test Category, 2018-2023 (millions $)
    • Table 7-18: Selected Self-Test Immunoassay Innovations
  • Pregnancy Testing
  • Cardiovascular Diagnostics
  • Drugs of Abuse/Therapeutic Drug Monitoring
    • Table 7-19: Selected POC Test Innovations
    • Table 7-20: Selected POC Immunoassay Test Platforms
  • THE COMMERCIAL OUTLOOK FOR IMMUNOASSAYS

EIGHT: MOLECULAR ASSAYS

  • OVERVIEW
    • Table 8-1: Common Next Generation Molecular Test Traits
  • SAMPLE PREPARATION AND QUALITY CONTROL
    • Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
  • ADVANCED MOLECULAR TESTS AND TECHNOLOGIES
  • Exosome Sequencing
    • Table 8-3: Selected Exosome Test Innovations
  • Liquid Biopsy
    • Table 8-4: Selected Liquid Biospy Innovations
  • Metabolomic Profiling
  • Information Technology for Test Value
    • Table 8-5: Selected IT Innovations in Molecular Diagnostics
  • Forensic Studies - An Emerging Opportunity
    • Table 8-6: Selected Innovations in Forensic DNA Testing
  • Test Platforms
    • Table 8-7: Key Molecular Technologies and Major Players
    • Table 8-8: Selected Molecular Test Platform Innovations
  • MAJOR PLAYERS
    • Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2013-2017 (in millions $)
  • MARKET ANALYSIS
    • Table 8-10: Worldwide Molecular Test Sales by Type 2018-2023
  • Oncology
  • Pharmacodiagnostics
    • Table 8-11: Selected Molecular Tumor Marker Test Innovations
  • Inherited Diseases and Thrombophilia SNPs
    • Table 8-12: Most Frequently Requested Genetic Tests
    • Table 8-13: Selected Genomic Tests for Inherited Diseases
  • Prenatal and Newborn Testing
    • Table 8-15: Prenatal Services Provided
    • Table 8-16: Selected Molecular Tests for Prenatal Analysis
  • Tissue Typing
    • Table 8-17: Selected HLA Typing Test Innovations
  • THE COMMERCIAL OUTLOOK FOR MOLECULAR TESTS

NINE: HEMATOLOGY

  • OVERVIEW OF HEMATOLOGY AND TRENDS
  • Digital Image Analysis
    • Table 9-1: CellaVision Placement Data by Hematology Vendor (as of February 2017)
    • Table 9-2: Selected Hematology Image Analysis Innovations, 2014-2018
  • Digital Evolution
  • Quality Control Measurement Programs
  • LABORATORY-BASED HEMATOLOGY TESTING
    • Table 9-3: Selected Hematology Innovations, 2014-2018
    • Table 9-4: Laboratory-based Hematology Test and Instrument Market, 2018 and 2023 ($ millions)
  • Regional Laboratory-based Hematology Test and Instrument Market
    • Figure 9-1: Laboratory-based Hematology Test and Instrument Market, Regional Analysis, 2017
  • DECENTRALIZED HEMATOLOGY TESTING
  • Hemoglobin/Hematocrit at the POC
    • Table 9-5: Selected POC Hematology Innovations, 2016-2018
    • Table 9-6: Decentralized Hematology Test and Instrument Market, 2018 and 2023 ($ millions)
  • Regional Decentralized Hematology Test and Instrument Market
    • Figure 9-2: Decentralized Hematology Test and Instrument Market, Regional Analysis, 2017
  • MARKET ANALYSIS: LEADING SUPPLIERS
    • Table 9-7: Top Hematology, including d-dimer, Company Revenues, (laboratory and POC), 2017 ($ millions)
  • THE COMMERCIAL OUTLOOK FOR HEMATOLOGY TESTS

TEN: COAGULATION

  • OVERVIEW AND TRENDS OF COAGULATION AND IMMUNOHEMATOLOGY TESTS
  • SPECIAL TOPICS
  • Direct Oral Anticoagulants (DOACs)
  • D-dimer
  • MARKET ANALYSIS
    • Table 10-1: Global Coagulation Sales by Segment, 2018-2023 ($millions)
    • Figure 10-1: Global Coagulation Test and Instrument Market, Regional Analysis, 2017
  • LAB-BASED TESTING
    • Table 10-2: Selected Lab-based Coagulation Innovations, 2015-2018
  • Genetic Markers of Hypercoagulopathies
    • Table 10-3: Selected Molecular Coagulation Test Innovations
  • LEADING SUPPLIERS: LABORATORY SYSTEMS
    • Table 10-4: Top Coagulation Company Revenues, Laboratory-based - 2017 ($ millions)
  • DECENTRALIZED COAGULATION TESTING - PROFESSIONAL USE
  • Decentralized Coagulation Testing - OTC
    • Table 10-5: Selected POC Coagulation Test Innovations
  • Platelet Testing
    • Table 10-6: Selected Platelet Activity Test Innovations
  • LEADING SUPPLIERS: POC SYSTEMS
    • Table 10-7: Top Coagulation Company Revenues, POC - 2017 ($ millions)
  • THE COMMERCIAL MARKET FOR COAGULATION TESTS
    • Table 10-8: Major Anticoagulants Uses and Tests

ELEVEN: MICROBIOLOGY AND VIROLOGY

  • THE BURDEN OF INFECTIOUS DISEASE
    • Table 11-1: The Top Ten Leading Causes of Death
  • HIDDEN COSTS OF NON-DETECTION: SECONDARY EFFECTS
  • Herpes and Alzheimer's Disease
  • Ebola and Cancer
  • HIV and Cancer
  • H pylori and Cancer
  • Bacteria and Parkinson's
  • MICROBIAL ANTIBIOTIC RESISTANCE - THE ROLE OF CLINICAL TESTS
  • The Holy Grail - Faster Identification
    • Table 11-2: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
  • TRADITIONAL MICROBIOLOGY AND ITS LIMITS
  • THE NEW MICROBIOLOGY - INNOVATIONS
  • Liquid Based Microbiology and Automation Innovations
  • Post-Blood Culture Microbial ID
  • PCR and Other NAAT-Based Tests for Infectious Diseases
    • Table 11-3: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
  • Microbiome-Related Microbiology Tests
    • Table 11-4: Selected Microbiome-Based Tests
  • Next Generation Sequencing-Based Microbiology Approaches
    • Table 11-5: Selected Companies Applying DNA/RNA Sequencing to Microbiology
  • Syndromic Testing
  • EMERGING INFECTIOUS DISEASE THREATS
    • Table 11-6: Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats
  • Tickborne Diseases: Beyond Lyme
  • Zika
  • Chagas
  • Dengue
  • Ebola
  • Chikungunya
  • Next Threats?
  • MICROBIOLOGY FIRMS MIX AND MATCH
  • MARKET ANALYSIS
  • MARKET ANALYSIS - TRADITIONAL MICROBIOLOGY ID/AST
    • Table 11-7: Microbiology ID/AST Market, 2018-2023 (in millions USD)
  • ID/AST
  • Blood Culture
    • Table 11-8: Selected Advanced Techniques in Positive Blood Culture
  • Chromogenic Media
  • Rapid Tests Performed on Colonies from Culture Media
  • Supplies
  • MARKET ANALYSIS - MICROBIOLOGY IMMUNOASSAYS
  • Improvements in Microbiology Immunoassays
    • Table 11-9: Selected Infectious Disease Immunoassay Innovations
    • Table 11-10: World Clinical Laboratory Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2018
  • Hepatitis Testing
  • Sepsis
  • HIV Immunoassay Testing
    • Table 11-11: Selected HIV Assays
  • Sexually Transmitted Diseases (STDs)
  • TORCH
  • Lyme Disease
  • Rapid Immunoassay Tests
  • MARKET ANALYSIS - MOLECULAR MICROBIOLOGY
    • Table 11-12: Worldwide Molecular Microbiology Market, by Pathogen/Disease Indication, 2018-20223
  • Molecular Respiratory Infection Testing
    • Table 11-14: Selected Molecular Point of Care Innovations in Microbiology
  • Molecular Testing for Sexually Transmitted Diseases
  • Molecular Hepatitis Testing
  • Molecular HIV Testing
  • Molecular Tests for Hospital-Acquired Infections (HAIs)
    • Table 11-15: Frequency of the Most Common Nosocomial Infections
  • Clostridium Difficile
  • MRSA
  • Molecular TB Testing
  • Limitations of Molecular Microbiology Testing
  • MASS SPECTROMETRY
    • Table 11-16: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
  • THE FUTURE OUTLOOK FOR MICROBIOLOGY

TWELVE: BLOOD BANKING SERVICES

  • INTRODUCTION
    • Table 12-1: History of Blood Testing
  • THE CURRENT STATUS OF GLOBAL BLOOD COLLECTION
    • Table 12-2: Distribution of Blood Units Collected
  • GLOBAL BLOOD SAFETY
    • Table 12-3: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
    • Table 12-4: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
  • Zika Virus
  • BLOOD AND COMPONENT COLLECTION
    • Table 12-5: Blood Component Usage for Selected Conditions
    • Table 12-6: Red Blood Cell and Platelet Use by Hospital Services
  • REEVALUATING BLOOD TRANSFUSIONS
    • Table 12-7: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
  • BLOOD TYPING AND GROUPING MARKET
    • Table 12-8: Blood Typing Market, 2018-2023 (Typing)
  • Manual Blood Typing Methods
  • Automated Blood Typing and Screening Methods
  • Molecular Methods
  • Reducing Blood Typing Errors
    • Table 12-9: Selected Blood Typing and Grouping Innovations
  • Size and Growth of Typing Markets
  • BLOOD TESTING MARKET
    • Table 12-10: Selected Blood Testing Innovations
  • Preventing Bacterial Infections
  • Immunoassays
  • Nucleic Acid Testing (NAT)
  • Size and Growth of the Market
    • Table 12-11: Blood Banking Diagnostics Market, 2018-2023 (Typing, Immunoassay Screen, NAT Screens)
  • Blood Testing Market by Geography
    • Figure 12-1: Blood Testing Market by Geography
  • THE COMMERCIAL OUTLOOK FOR BLOOD BANKING TESTING

THIRTEEN: HISTOLOGY AND CYTOLOGY

  • OVERVIEW
  • SPECIAL TOPICS
  • Histology Automation
    • Table 13-1: Selected Histology Lab Automation
    • Table 13-2: Histology Information Technology Tools
  • Advanced Analysis Solutions
    • Table 13-3: Selected Advanced Histology Techniques
  • HPV Goes Core Lab
    • Table 13-4: Selected HPV Test Innovations
  • MARKET ANALYSIS
    • Table 13-5: Worldwide Histology/Cytology Sales by Type, 2018-2023 ($ millions)
  • Histology/Cytology
    • Table 13-6: Revenues of the Major Histology Companies, 2012-2017 ($ millions, estimated)
    • Table 13-7: Selected Vendors of Traditional Histology Stains
  • Immunohistochemistry and In Situ Hybridization
    • Table 13-8: Selected In Situ Hybridization-based Tests
    • Table 13-9: Selected IHC Test Innovations
  • Pharmacodiagnostic Histology
    • Table 13-10: Major Pharmacodiagnostic Markers
    • Table 13-11: Selected Pharmacodiagnostic Histology Tests
  • Digital Imaging and Computational Pathology
    • Table 13-12: Selected Digital Imaging Innovations
  • Circulating Tumor Cells
    • Table 13-13: Selected Innovations in CTC Technology
  • Flow Cytometry
  • THE COMMERCIAL OUTLOOK FOR HISTOLOGY AND CYTOLOGY TESTS

FOURTEEN: COMPANY PROFILES: THE TOP TIER

  • ABBOTT DIAGNOSTICS
  • Key Comment
  • Recent Revenue History
  • 2016-2017 Business Highlights
  • Alere Acquisition Update
  • Core Lab
  • Coagulation
  • Infectious Diseases - Molecular
  • Diabetes
  • iSTAT Business
  • Companion Testing
  • Liquid Biopsy
  • Zika
  • Alere Performance
  • Recent Revenue History
  • Innovation Milestones
  • Abbott Acquisition Update
  • Diabetes
  • HIV
  • Alere Reader
  • Coagulation
  • Molecular POC
  • Market Expansion
  • ARKRAY
  • Key Comment
  • Recent Revenue History
  • Molecular
  • Immunoassays
  • Urinalysis
  • Diabetes
  • BECKMAN COULTER, INC. / DANAHER
  • Key Comment
  • Hematology
  • Clinical Chemistry
  • Immunoassays
  • Coagulation
  • Microbiology
  • Lab Management
  • Molecular Tissue Analysis
  • Flow Cytometry
  • Urinalysis
  • A Fight for BNP Rights
  • BECTON, DICKINSON AND COMPANY (BD)
  • Key Comment
  • Recent Revenue History
  • Cytology
  • BD Max Molecular
  • ID/AST
  • Connectivity
  • POC Veritor
  • Mass Spectrometry
  • Blood Collection
  • Flow Cytometry
  • Licensing
  • BIOMEacute;RIEUX INC.
  • Key Comment
  • Recent Revenue History
  • Traditional Microbiology
  • Blood Culture
  • Immunoassays
  • Mass Spectrometry
  • Platelet Safety
  • Sequencing
  • Sample Preparation, Molecular
  • Data Analysis
  • BioFire Diagnostics Business
  • BIO-RAD LABORATORIES, INC.
  • Key Comment
  • Recent Revenue History
  • Company Highlights
  • Quality Control
  • Blood Bank
  • Infectious Diseases - Molecular
  • Immunoassays
  • Liquid Biopsy
  • Microbiome
  • Droplet Digital PCR
  • Sequencing
  • DANAHER CORPORATION
  • Key Comment
  • ecent Revenue History
  • DIASORIN S.P.A.
  • Key Comment
  • Recent Revenue History
  • Development Plan
  • Expansion
  • Immunoassays
  • Zika Testing
  • Molecular
  • GRIFOLS S.A.
  • Key Comment
  • Blood Transfusion Business
  • Blood Bank CLIA Lab
  • Coagulation
  • HOLOGIC, INC.
  • Key Comment
  • Recent Revenue History
  • Panther Molecular System
  • Panther Fusion
  • Blood Bank - Zika Virus
  • Collaboration
  • INSTRUMENTATION LABORATORY (IL) / WERFEN
  • Key Comment
  • Recent Revenue History
  • Expansion
  • Coagulation
  • Critical Care
  • Information Technology
  • ORTHO CLINICAL DIAGNOSTICS (ORTHO)
  • Key Comment
  • Recent Revenue History
  • Blood Bank
  • Core Lab / Immunoassays
  • Lab Automation
  • Connectivity
  • QIAGEN N.V.
  • Key Comment
  • Recent Revenue History
  • Molecular Test Business
  • Prenatal Teting
  • Tuberculosis
  • Cancer and Companion Diagnostics
  • Digital Sequencing
  • Bioinformatics
  • Liquid Biopsy
  • Microbiome
  • Cervical Cancer
  • Transplant Medicine
  • Forensic
  • Expansion
  • RADIOMETER A/S / DANAHER
  • Key Comment
  • Recent Revenue History
  • POC
  • Critical Care
  • Immunoassays
  • ROCHE DIAGNOSTICS
  • Key Comment
  • Recent Revenue History
  • Hematology
  • Immunoassays
  • Global Access Program for HIV
  • Molecular Expansion
  • Core Molecular
  • Diabetes
  • Coagulation
  • cobas Liat System - POC
  • HPV
  • Blood Bank
  • Transplant Medicine
  • Cancer Companion Testing
  • Prenatal
  • Liquid Biopsy
  • Information Technology
  • SIEMENS HEALTHINEERS
  • Key Comment
  • Recent Revenue History
  • Business Expansion
  • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
  • Core Lab
  • Lab Automation
  • Hematology
  • Coagulation
  • Immunoassays
  • Molecular
  • Zika Virus Testing
  • Acute Care - POC
  • POC Connectivity
  • SYSMEX CORPORATION
  • Key Comment
  • Recent Revenue History
  • Business Expansion
  • Hematology
  • Coagulation
  • Urinalysis
  • Forging New Markets
  • Companion Test Diagnostics
  • Exosomes
  • Sysmex Inostics
  • THERMO FISHER SCIENTIFIC INC.
  • Key Comment
  • Recent Revenue History
  • Immunoassays
  • Microbiology
  • Molecular Test Business
  • Next Generation Sequencing
  • Oncology Companion Diagnostics
  • Liquid Biopsy
  • Zika
  • Transplant Medicine
  • Quality Control IT
  • Point of Care
  • Mass Spectrometry
  • Forensic
  • Expansion
  • Research
  • WERFEN
  • Key Comment
  • Recent Revenue History
  • Instrumentation Laboratory
  • Inova Diagnostics
  • Biokit

FIFTEEN: COMPANY PROFILES: THE SECOND TIER

  • AGILENT TECHNOLOGIES
  • Key Comment
  • Recent Revenue History
  • Agilent in Genomics
  • Cytogenetic Analysis
  • Sequencing
  • CRISPR
  • Dako
  • BGI GENOMICS (FORMERLY BEIJING GENOME INSTITUTE)
  • Key Comment
  • Recent Revenue History
  • Prenatal Testing
  • Test Services
  • Liquid Biopsy
  • With Complete Genomics
  • Advancements
  • CEPHEID / DANAHER
  • Key Comment
  • Recent Revenue History
  • Tuberculosis
  • Microbiology
  • Respiratory Infections
  • GeneXpert Omni - POC molecular
  • POC TESTING
  • Cancer
  • EIKEN CHEMICAL CO., LTD
  • Key Comment
  • Recent Revenue History
  • FUJIFILM WAKO PURE CHEMICAL CORPORATION
  • Key Comment
  • Recent Revenue History
  • Products
  • FUJIREBIO DIAGNOSTICS, INC.
  • Key Comment
  • Recent Revenue History
  • Molecular
  • ILLUMINA
  • Key Comment
  • Recent Revenue History
  • Reported Highlights in 2016 and 2017
  • Sequencing
  • Advancing in the Clinical Market
  • Sequencing Data Analysis
  • Sample Preparation
  • Microarrays
  • Project Firefly
  • Liquid Biopsy
  • Forensic Medicine
  • Prenatal Testing Business
  • LABCORP, LABORATORY CORPORATION OF AMERICA
  • Key Comment
  • Recent Revenue History
  • LabCorp Buys Sequenom
  • Diagnostics Services
  • Prenatal
  • Retail Outlets
  • LUMINEX CORPORATION
  • Key Comment
  • Recent Revenue History
  • Assay Development
  • Verigene Business
  • Business Expansion
  • MERIDIAN BIOSCIENCE, INC.
  • Key Comment
  • Diagnostics Business Unit
  • Recent Revenue History
  • Immunoassays
  • Molecular Tests
  • Sample Collection
  • MINDRAY MEDICAL INTERNATIONAL LIMITED
  • Key Comment
  • Recent Revenue History
  • Core Lab
  • Hematology
  • Coagulation
  • PERKINELMER, INC. (PE)
  • Key Comment
  • Recent Revenue History
  • Diagnostics
  • Sequencing
  • Histology
  • Prenatal Business
  • Lab Services
  • Mass Spectrometry
  • PHILIPS (ROYAL PHILIPS)
  • Key Comment
  • Histology
  • Cancer Genomics
  • Patient Monitoring
  • Point of Care
  • Wearable Self Monitor
  • QUEST DIAGNOSTICS
  • Key Comment
  • Recent Revenue History
  • Reported Highlights
  • Diagnostic Services
  • Oncology
  • Infectious Diseases
  • Prenatal and Women's Health
  • Neurology
  • Retail / Direct to Consumer
  • QUIDEL CORPORATION
  • Key Comment
  • Recent Revenue History
  • The Alere Triage Business
  • Immunoassays
  • Rapid Immunoassays
  • The Solana Business
  • Molecular - Savanna
  • RANDOX LABORATORIES LTD.
  • Key Comment
  • Recent Revenue History
  • Clinical Chemistries
  • Controls
  • Evidence Series - Multistat Biochip Analyzers
  • Molecular
  • VENTANA MEDICAL SYSTEMS INC. / ROCHE TISSUE DIAGNOSTICS
  • Key Comment
  • Recent Revenue History
  • Immunohistochemistry - IHC
  • Histology
  • Companion Diagnostics
  • Quality Control
  • DISCOVERY Product Line

SIXTEEN: COMPANY PROFILES: BLOOD BANK SPECIALISTS

  • BLOODSOURCE
  • CERUS CORPORATION
  • Recent Revenue History
  • HAEMOKINESIS PT
  • IMMUCOR
  • Recent Revenue History
  • Transfusion Medicine
  • Transplant Diagnostics
  • IMMUCOR DX Laboratory Service
  • MICROTYPING CONCEPTS
  • MICRONICS
  • QUOTIENT LIMITED
  • Recent Revenue History
  • Traditional Blood Grouping
  • MosaiQ Platform
  • RELIANCE LIFE SCIENCES

SEVENTEEN: COMPANY PROFILES: COAGULATION SPECIALISTS

  • DIAGNOSTICA STAGO, S.A.S.
  • Instrumentation
  • Test Kits
  • MICROVISK TECHNOLOGIES
  • DIAGON KFT. HUNGARY

EIGHTEEN: COMPANY PROFILES: CORE LAB AND OTHER COMPANIES

  • AB SCIEX PTE LTD.
  • EKF DIAGNOSTICS HOLDINGS PLC
  • EKF Diagnostics Holdings Recent Revenue History ($ millions, converted from GBP)
  • Lab-based Assays
  • Molecular
  • ELITECH GROUP S.A.S.
  • ERBA DIAGNOSTICS, INC.
  • MEDTEST DX
  • MICROSAIC SYSTEMS PLC
  • Microsaic Systems Recent Revenue History ($ millions, converted from GBP)
  • NOVA BIOMEDICAL
  • Diabetes
  • SCIENION AG
  • SEKISUI DIAGNOSTICS
  • SHIMADZU SCIENTIFIC INSTRUMENTS
  • SNIBE CO. LTD., (SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD.)
  • TECAN GROUP
  • Tecan Group Recent Revenue History ($ millions, converted from CHF)
  • TOSOH BIOSCIENCE
  • TRINITY BIOTECH PLC
  • Trinity Biotech Recent Revenue ($ millions)

NINETEEN: COMPANY PROFILES: CTC & LIQUID BIOPSY TEST PROVIDERS

  • ANGLE, PLC
  • BIOCARTIS
  • Recent Revenue History
  • Connectivity
  • DMAT Instrumentation - MyCartis
  • Idylla News
  • Infectious Diseases
  • Collaborations
  • BIOCEPT, INC.
  • BIODESIX
  • CYNVENIO BIOSYSTEMS
  • EPIC SCIENCES
  • EPIGENOMICS AG
  • FOUNDATION MEDICINE, INC.
  • Recent Revenue History
  • Collaborations
  • GENOMIC HEALTH
  • Recent Revenue History
  • Market Uptake
  • Liquid Biopsy
  • Service Spin-off
  • GUARDANT HEALTH, INC.
  • MENARINI-SILICON BIOSYSTEMS
  • MYRIAD GENETICS, INC.
  • NATERA
  • Recent Revenue History
  • Products
  • NEOGENOMICS

TWENTY: DIABETES SPECIALISTS

  • ANIMAS CORPORATION
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • BIGFOOT BIOMEDICAL INC.
  • CELLNOVO GROUP SA
  • Recent Revenue History
  • DEBIOTECH SA
  • DEXCOM INC.
  • Recent Revenue History
  • GENTAG INC.
  • GLOOKO INC.
  • GLYSURE LIMITED
  • GLYTEC LLC
  • IHEALTH LABS INC.
  • INSULET CORPORATION
  • Recent Revenue History
  • INTEGRITY APPLICATIONS INC.
  • LIFESCAN INC.
  • MEDTRONIC PLC
  • Recent Revenue History
  • NEMAURA MEDICAL INC.
  • NIGHTSCOUT PROJECT
  • SANOFI
  • TRIVIDIA HEALTH INC.
  • VERILY LIFE SCIENCES LLC

TWENTY-ONE: COMPANY PROFILES: HEMATOLOGY (CELL ANALYSIS) SPECIALISTS

  • CELLAVISION AB
  • Recent Revenue History
  • HORIBA MEDICAL
  • Recent Revenue History
  • Chemistry
  • MEDICA CORPORATION
  • ONCA XT LTD
  • WEST MEDICA

TWENTY-TWO: COMPANY PROFILES: HISTOPATHOLOGY SPECIALISTS

  • ADVANCED CELL DIAGNOSTICS (ACD)
  • AMOY DIAGNOSTICS CO. LTD.
  • Amoy Diagnostics Recent Revenue History ($ millions, converted from CNY)
  • APPLIED SPECTRAL IMAGING INC. (ASI)
  • BIOGENEX LABORATORIES, INC.
  • BIOVIEW LTD.
  • Recent Revenue History ($ millions, converted from NIS)
  • CIRCULOMICS INC.
  • DAKO A/S
  • Special Stains
  • Immunohistochemistry (ICH)
  • Companion Diagnostics
  • Flow Cytometry
  • Automation
  • Alliances
  • DEFINIENS
  • HTG MOLECULAR DIAGNOSTICS
  • HTG Molecular Diagnostics Recent Revenue History ($ millions)
  • Strategic Partnerships
  • KAPA BIOSYSTEMS INC.
  • LEICA BIOSYSTEMS
  • Collaborations
  • MILLIPORESIGMA (FORMERLY EMD MILLIPORE)
  • OMNYX LLC
  • VISIOPHARM

TWENTY-THREE: COMPANY PROFILES: IMMUNOASSAY SPECIALISTS

  • BG MEDICINE, INC
  • Recent Revenue History
  • BINDING SITE GROUP LTD. (THE)
  • BIOHIT OYJ (BIOHIT HEALTHCARE)
  • Recent Revenue History
  • Market Expansion
  • BIOMERICA INC.
  • Recent Revenue History
  • BIO-TECHNE CORPORATION
  • Recent Revenue History
  • CORGENIX MEDICAL CORPORATION
  • CRITICAL DIAGNOSTIC
  • DIAXONHIT (EUROBIO SCIENTIFIC)
  • Recent Revenue History
  • EUROIMMUN AG
  • Recent Revenue History
  • HOB BIOTECH
  • IMMUNODIAGNOSTIC SYSTEMS (IDS)
  • Recent Revenue History
  • INOVA DIAGNOSTICS, INC.
  • INTEGRATED DIAGNOSTICS (NOW BIODESIX)
  • ONE LAMBDA
  • ORGENTEC DIAGNOSTIKA
  • PROTAGEN DIAGNOSTICS
  • RESPONSE BIOMEDICAL CORP.
  • Recent Revenue History
  • SINGULEX, INC.
  • THERADIG
  • Recent Revenue History
  • VOLITIONRX LIMITED

TWENTY-FOUR: INFORMATION TECHNOLOGY SPECIALISTS IN IN VITRO DIAGNOSTICS

  • ADVAITA CORP.
  • CERNER CORP.
  • DELL TECHNOLOGIES INC.
  • DESKTOP GENETICS LTD.
  • DNANEXUS INC.
  • EDICO GENOME
  • EUFORMATICS OY
  • GENALICE
  • GENOMONCOLOGY LLC
  • GOOGLE LLC
  • HUMAN LONGEVITY INC.
  • INTERNATION BUSINESS MACHINES CORP. (IBM)
  • INTEL CORPORATION
  • N-OF-ONE
  • PIERIANDX
  • RENNOVA HEALTH, INC.
  • SOPHIA GENETICS SA
  • SUNQUEST INFORMATION SYSTEMS INC.
  • WUXI NEXTCODE

TWENTY-FIVE: COMPANY PROFILES: MICROBIOLOGY SPECIALISTS

  • ACCELERATE DIAGNOSTICS, INC.
  • Recent Revenue History
  • Company Overview
  • ADVANCED BIOLOGICAL LABORATORIES, S.A. (ABL)
  • ADVANDX, INC.
  • ALTONA DIAGNOSTICS
  • Selected altona Diagnostics POCTs for the Diagnosis of Illnesses Covered by Emergency Use Authorizations (EUAs) Currently in Effect
  • ARCDIA INTERNATIONAL OY LTD.
  • BIOFIRE DIAGNOSTICS, LLC. (ACQUIRED BY BIOMEacute;RIEUX)
  • Recent Revenue History and Other Financial Information
  • Company Overview
  • BRUKER BIOSCIENCES CORPORATION
  • Recent Revenue History
  • Company Overview
  • Microbiology
  • Tissue Analysis
  • COPAN ITALIA S.P.A. AND COPAN DIAGNOSTICS, INC.
  • Lab Automation
  • Partnerships
  • Swabs
  • CURETIS
  • Recent Revenue History
  • Company Overview
  • FAST TRACK DIAGNOSTICS (ACQUIRED BY SIEMENS HEALTHINEERS)
  • FOCUS DIAGNOSTICS, INC.
  • GENETIC ANALYSIS AS
  • GENEWEAVE BIOSCIENCES, INC.
  • About Smarticle Technology
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • Preanalytical Products
  • HAIN LIFESCIENCE GMBH
  • MAST GROUP
  • MOBIDIAG LTD.
  • NANOSPHERE, INC. (LUMINEX)
  • Recent Revenue History
  • Company Overview
  • POSITIVEID CORPORATION
  • Recent Revenue History
  • Company Overview
  • Q-LINEA AB
  • SEEGENE, INC.
  • Recent Revenue History
  • Company Overview
  • Collaborations
  • Molecular Diagnostic Systems
  • Assay Panels
  • Instrumentation
  • SPECIFIC TECHNOLOGIES
  • Company Overview
  • Developments
  • SYNBIOSIS LTD.
  • T2 BIOSYSTEMS
  • Recent Revenue History
  • Company Overview
  • Financing
  • Collaborations
  • Assays
  • VIROCYT, LLC

TWENTY-SIX: COMPANY PROFILES: MOLECULAR TEST SPECIALISTS

  • ASURAGEN INC.
  • Controls
  • Sample Collection
  • Sequencing
  • AUTOGENOMICS INC.
  • ENZO BIOCHEM INC.
  • Recent Revenue History
  • IP Situation
  • EXOSOME DIAGNOSTICS, INC.
  • FLUIDIGM CORPORATION
  • Recent Revenue History
  • GENMARK DIAGNOSTICS, INC
  • Recent Revenue History
  • GENOME DIAGNOSTICS BV (GENDX)
  • NANOSTRING TECHNOLOGIES, INC.
  • Recent Revenue History
  • Immunohistochemistry
  • Alliances
  • LDTs
  • OXFORD NANOPORE TECHNOLOGIES LTD
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACBIO)
  • Recent Revenue History
  • QUANDX INC
  • RAINDANCE TECHNOLOGIES, INC.
  • Recent Revenue History
  • RUBICON GENOMICS, INC.
  • TAKARA BIO INC.
  • TROVAGENE, INC.
  • Recent Revenue History
  • VELA DIAGNOSTICS
  • WAFERGEN BIO-SYSTEMS, INC.

TWENTY-SEVEN: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS

  • ABAXIS, INC.
  • Recent Revenue History
  • ABINGDON HEALTH LTD.
  • ATLAS GENETICS LTD.
  • BIOMEME, INC.
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
  • Recent Revenue History
  • DNA ELECTRONICS LTD (DNAE)
  • ENTOPSIS
  • FABPULOUS B.V.
  • FIO CORPORATION
  • GENEDRIVE PLC (FORMERLY EPISTEM HOLDINGS)
  • Recent Revenue History
  • HEMA DIAGNOSTIC SYSTEMS (HDS; DBA NUGENEREX DIAGNOSTICS)
  • IMEC
  • INSILIXA INC.
  • LOOP MEDICAL (FORMERLY QLOUDLAB SA)
  • MEDMIRA, INC.
  • Recent Revenue History
  • ORASURE TECHNOLOGIES, INC.
  • Recent Revenue History
  • The Genotek Business
  • PTS DIAGNOSTICS
  • QUANTUMDX GROUP, LTD.
  • RHEONIX, INC.
  • SAMSUNG HEALTHCARE
  • VEREDUS LABORATORIES PTE LTD

TWENTY-EIGHT: COMPANY PROFILES: PRENATAL TEST SERVICE PROVIDERS

  • AFFYMETRIX, INC.
  • Company Overview
  • Products
  • BERRY GENOMICS CO. LTD.
  • Company Overview
  • Products
  • COMBIMATRIX (INVITAE)
  • Company Overview
  • Products
  • COOPERGENOMICS (DIVISION OF COOPERSURGICAL)
  • Company Overview
  • Products
  • COUNSYL
  • Company Overview
  • Products
  • GENEPEEKS, INC.
  • Company Overview
  • Products
  • GENETADI BIOTECH S.L.
  • Company Overview
  • Products
  • GENOMA GROUP
  • Company Overview
  • Products
  • INNOVATIONS EXCHANGE PTE LTD (INEX) AND IGENE DIAGNOSTICS PTE LTD
  • Company Overview
  • Products
  • LIFECODEXX AG
  • Company Overview
  • Products
  • OXFORD GENE TECHNOLOGY
  • Company Overview
  • Products
  • PREMAITHA HEALTH
  • Company Overview
  • Products
  • Company Financials
  • RAVGEN
  • Company Overview
  • Products
  • REPRODUCTIVE GENETICS INNOVATIONS
  • Company Overview
  • Products
  • SEQUENOM, INC.
  • Company Overview
  • Products

TWENTY-NINE: COMPANY PROFILES: QUALITY CONTROL & SAMPLE PRETREATMENT SPECIALISTS

  • 10X GENOMICS
  • AGENA BIOSCIENCE, INC.
  • Market Expansion
  • BIOTYPE DIAGNOSTIC GMBH
  • Sampletype i-sep System
  • Partnership with Qiagen
  • DXTERITY DIAGNOSTICS INC.
  • HORIZON DISCOVERY GROUP PLC
  • Recent Revenue History
  • Company Overview
  • Acquisition of Dharmacon
  • Collaborations
  • Gene Editing
  • INCELLDX
  • OASIS DIAGNOSTICS CORPORATION
  • PRECIPIO, INC. (FORMERLY TRANSGENOMIC)
  • PREANALYTIX GMBH
  • QUANTERIX CORPORATION
  • Recent Revenue History
  • Company Overview
  • SERACARE LIFE SCIENCES, INC.
  • Selected Products
  • Collaborations, etc.
  • STRECK INC.
  • Selected Products
  • Distribution Deals

THIRTY: TEST SERVICE PROVIDERS

  • 23ANDME
  • The Move to Building a Research Company
  • Therapeutics Group
  • Ancestry
  • Outside the U.S.
  • AGENDIA BV
  • Agendia Recent Revenue History (estimated, $ millions)
  • AMBRY GENETICS
  • Ambry Genetics Recent Revenue History ($ millions)
  • Epilepsy
  • Oncology
  • Cardiac
  • Prenatal
  • Information Technology
  • ARUP LABORATORIES
  • ASSUREX HEALTH
  • THE BIOCOLLECTIVE
  • BIOREFERENCE LABORATORIES
  • BIOTHERANOSTICS
  • BLUEPRINT GENETICS OY
  • BOSTON HEART DIAGNOSTICS
  • CAREDX, INC.
  • CareDx Recent Revenue History ($ millions)
  • Sequencing
  • CLEVELAND HEARTLAB INC.
  • EUROFINS GENOMICS
  • EXACT SCIENCES CORP.
  • Exact Sciences Recent Revenue History ($ millions)
  • GENOMIC VISION
  • Genomic Vision Recent Revenue History ($ millions, converted from euros)
  • HELOMICS CORPORATION
  • MAYO MEDICAL LABORATORIES
  • Information Technology
  • Reference Laboratory Services
  • MDXHEALTH SA
  • MDxHealth Recent Revenue History ($ millions)
  • OPKO DIAGNOSTICS
  • OPKO Diagnostics Recent Revenue History ($ millions)
  • PATHWAY GENOMICS CORPORATION
  • SONIC HEALTHCARE
  • Sonic Healthcare Recent Revenue History (estimated clinical lab revenue, by region, $ millions)
  • VERACYTE, INC.
  • Veracyte Recent Revenue History ($ millions)
  • VERMILLION INC.
  • Vermillion Recent Revenue History ($ millions)
Back to Top
전화 문의
이용안내
 
BCC Research